
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
My patients have been more satisfiedwith my care and more compliantwith medical advice since I starteddictating my notes in front ofthem at the conclusion of our officevisits.
My patients have been more satisfied with my care and more compliant with medical advice since I started dictating my notes in front of them at the conclusion of our office visits. In addition, it is quicker and more accurate than dictating later, and it affords both patient and physician an opportunity to clarify any miscommunication.
-- Li Schmidt, MD
Tucson, Ariz






